Encouraging expanded domestic manufacturing capacity in Canada for select drugs so that there are more than one producer for key medicines is among the actions that are up for discussion in a consultation document from Health Canada on how prevent drug shortages.
Over 40 Questions From Health Canada On How To Prevent Drug Shortages
Expanding the scope of the mandatory public shortage reporting framework and requiring risk management plans for shortages in certain situations are among the actions that Health Canada wants drug companies and other stakeholders to consider in its consultation on improving access to drugs.
More from Distribution/Supply Chain
• By
The rollout of Trump’s plan has been a policy whiplash, but despite a 90-day pause on tariffs, the US president still appears to be holding a grudge with industry over drug pricing.
• By
Sector-specific tariffs, including on pharmaceuticals, could be announced as early as this week.
• By
Amid ongoing generic drug supply problems, Japan's government is to set up a new fund to support corporate investments geared towards manufacturing and consolidation.
• By
Newly proposed legislation for bolstering the EU’s drug manufacturing capacity and reducing its overreliance on foreign manufacturers includes a number of measures, such as a requirement for EU countries to prioritize the security of supply over price when procuring drugs.
More from Compliance
• By
Faced with Trump’s hostile tariff moves, the UK aims to speed up clinical trial start times to support its pharma sector and invest £600m in a new health data research service.
• By
While the pharma industry appears to be exempt from US tariffs imposed by President Trump, a member of the UK House of Lords says the details are unknown and warned that uncertainty “leads to less investment” in business as a whole.
• By
Trump announced a 26% reciprocal tariff on India, but a country-agnostic exemption of pharmaceuticals implies that the interests of Indian firms are protected for now. What is Indian pharma’s business exposure and what is domestic industry saying?